Short Interest in Enzolytics, Inc. (OTCMKTS:ENZC) Drops By 19.4%

Enzolytics, Inc. (OTCMKTS:ENZC) saw a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 291,000 shares, a drop of 19.4% from the May 31st total of 360,900 shares. Based on an average daily trading volume, of 18,153,500 shares, the short-interest ratio is currently 0.0 days.

Enzolytics Stock Performance

Shares of OTCMKTS ENZC opened at $0.00 on Tuesday. Enzolytics has a 12 month low of $0.00 and a 12 month high of $0.06.

Enzolytics Company Profile

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.